- Home
- NOTE vs CVM Comparison
NOTE vs CVM Comparison
Compare NOTE & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOTE
- CVM
- Stock Information
- Founded
- NOTE 2013
- CVM 1983
- Country
- NOTE United States
- CVM United States
- Employees
- NOTE N/A
- CVM N/A
- Industry
- NOTE EDP Services
- CVM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NOTE Technology
- CVM Health Care
- Exchange
- NOTE Nasdaq
- CVM Nasdaq
- Market Cap
- NOTE 63.9M
- CVM 60.9M
- IPO Year
- NOTE N/A
- CVM 1987
- Fundamental
- Price
- NOTE $4.00
- CVM $7.59
- Analyst Decision
- NOTE Strong Buy
- CVM
- Analyst Count
- NOTE 4
- CVM 0
- Target Price
- NOTE $29.25
- CVM N/A
- AVG Volume (30 Days)
- NOTE 257.5K
- CVM 69.3K
- Earning Date
- NOTE 11-12-2025
- CVM 08-14-2025
- Dividend Yield
- NOTE N/A
- CVM N/A
- EPS Growth
- NOTE N/A
- CVM N/A
- EPS
- NOTE N/A
- CVM N/A
- Revenue
- NOTE $109,683,000.00
- CVM N/A
- Revenue This Year
- NOTE N/A
- CVM N/A
- Revenue Next Year
- NOTE $4.61
- CVM N/A
- P/E Ratio
- NOTE N/A
- CVM N/A
- Revenue Growth
- NOTE N/A
- CVM N/A
- 52 Week Low
- NOTE $3.80
- CVM $1.98
- 52 Week High
- NOTE $24.36
- CVM $32.70
- Technical
- Relative Strength Index (RSI)
- NOTE 41.52
- CVM 34.69
- Support Level
- NOTE $4.15
- CVM $8.50
- Resistance Level
- NOTE $4.54
- CVM $9.35
- Average True Range (ATR)
- NOTE 0.30
- CVM 0.64
- MACD
- NOTE -0.13
- CVM -0.20
- Stochastic Oscillator
- NOTE 1.81
- CVM 3.28
About NOTE FiscalNote Holdings Inc.
FiscalNote Holdings Inc is a provider of world-wide policy and market intelligence solutions. Leveraging AI and analytics, it delivers actionable legal and policy insights for businesses, government institutions, and nonprofits. Its suite of products includes FiscalNote Core, CQ Federal, and EU Issue Tracker, facilitating effective policy management and risk mitigation. With its analysis from FrontierView, Oxford Analytica, and Dragonfly Eye, it offers geopolitical and market intelligence services. Operating as one segment, it generates revenue by integrating policy intelligence into daily operations. Geographically the company generates the majority of its revenue from North America, Europe, Australia, and Asia, with the majority generated from North America.
About CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.